← United States · All US Insider Profiles
US INSIDER PROFILE · NON-SCORING RESEARCH
Klass Russell Kevin
Other | President
Identity: SEC reporting-owner CIK · Reporting-owner CIK: 0001999774
Purchase history
- Companies traded
- 1
- Purchases · 12M
- 6
- Purchases · 24M
- 11
- Average purchase
- $23.9K
- Median purchase
- $20.0K
- Gross purchase value
- $263.2K
Companies: Zomedica Corp.
11 SEC accession(s) · 0 joint-owner event(s). Values are reported Form 4 transaction values in USD.
Qualifying purchase disclosures
| Published | Company | Ticker | Role | Reported value | SEC source |
|---|---|---|---|---|---|
| 2026-05-26 | Zomedica Corp. | ZOMDF | President | $10.4K | Open filing |
| 2026-05-21 | Zomedica Corp. | ZOMDF | Other | $23.9K | Open filing |
| 2025-11-14 | Zomedica Corp. | ZOMDF | President | $15.0K | Open filing |
| 2025-11-12 | Zomedica Corp. | ZOMDF | President | $12.0K | Open filing |
| 2025-11-10 | Zomedica Corp. | ZOMDF | President | $500 | Open filing |
| 2025-11-07 | Zomedica Corp. | ZOMDF | President | $20.2K | Open filing |
| 2025-08-13 | Zomedica Corp. | ZOMDF | President | $42.2K | Open filing |
| 2025-08-12 | Zomedica Corp. | ZOMDF | President | $20.0K | Open filing |
| 2025-08-12 | Zomedica Corp. | ZOMDF | President | $10.0K | Open filing |
| 2025-03-18 | Zomedica Corp. | ZOM | President | $49.0K | Open filing |
| 2024-11-12 | Zomedica Corp. | ZOM | President | $60.0K | Open filing |
Post-purchase outcomes
Excess return = stock return − S&P 500 ETF (SPY adjusted close) return. Returns start on the first shared trading session on or after publication.
No completed point-in-time price outcome is available yet.
Research patterns
- First purchase in 12M
- 0/10
- Large purchase ≥ $100k
- 0/11
- Cluster buying · 15D
- 4/11
- Buying the dip
- 0/—
Routine / opportunistic: Not classifiable. These labels never affect the score or ranking.
Small samples remain visible but are not scored. This research enrichment never affects US-v1.1.